Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Equity Average (2016 - 2026)

Tenax Therapeutics' Equity Average history spans 5 years, with the latest figure at $9.5 million for Q4 2017.

  • On a quarterly basis, Equity Average fell 70.16% to $9.5 million in Q4 2017 year-over-year; TTM through Dec 2017 was $9.5 million, a 70.16% decrease, with the full-year FY2017 number at $13.0 million, down 66.45% from a year prior.
  • Equity Average hit $9.5 million in Q4 2017 for Tenax Therapeutics, down from $10.7 million in the prior quarter.
  • Over the last five years, Equity Average for TENX hit a ceiling of $48.8 million in Q3 2016 and a floor of -$1.7 million in Q2 2013.
  • Historically, Equity Average has averaged $15.8 million across 3 years, with a median of $11.7 million in 2017.
  • The widest YoY moves for Equity Average: up 63.92% in 2013, down 177.5% in 2013.
  • Tracing TENX's Equity Average over 3 years: stood at -$1.7 million in 2013, then skyrocketed by 1989.35% to $31.9 million in 2016, then tumbled by 70.16% to $9.5 million in 2017.
  • Business Quant data shows Equity Average for TENX at $9.5 million in Q4 2017, $10.7 million in Q3 2017, and $12.7 million in Q2 2017.